Literature DB >> 27460730

Downregulation of miR-145-5p correlates with poor prognosis in gastric cancer.

Y Zhang1, X Wen, X-L Hu, L-Z Cheng, J-Y Yu, Z-B Wei.   

Abstract

OBJECTIVE: The aim of this study was to explore the clinical significance of miR-145-5p expression in gastric cancer (GC). PATIENTS AND METHODS: Expression of miR-145-5p was evaluated by qRT- PCR in tumor and normal gastric tissues in 145 GC patients. The correlation between the miR-145-5p expression and clinicopathological parameters was investigated. Finally, the survival was assessed by the Kaplan-Meier method and proportional hazards model.
RESULTS: Expression levels of miR-145-5p in GC tissues were significantly lower than those in adjacent normal tissues (p < 0.001). MiR-145-5p expression was significantly associated with lymph node metastasis, metastasis stage, and distant metastasis (all p < 0.05). Furthermore, Patients with low miR-145-5p expression had poorer overall survival time than those with high miR-145-5p expression (p = 0.014). Moreover, univariate and multivariate Cox analysis showed that miR-145-5p was an independent prognostic indicator for OS (p = 0.011).
CONCLUSIONS: MiR-145-5p is down-expressed in GC, and can be used as a marker of poor prognosis in GC patients.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27460730

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  25 in total

1.  Diagnostic and prognostic significance of serum miR-145-5p expression in glioblastoma.

Authors:  Yao Zhang; Wei-Wei Ta; Peng-Fei Sun; Yi-Fan Meng; Cheng-Zong Zhao
Journal:  Int J Clin Exp Pathol       Date:  2019-07-01

2.  Assessment of lncRNA DANCR, miR-145-5p and NRAS axis as biomarkers for the diagnosis of colorectal cancer.

Authors:  Fatemeh Bahreini; Masoud Saidijam; Zahra Mousivand; Rezvan Najafi; Saeid Afshar
Journal:  Mol Biol Rep       Date:  2021-05-06       Impact factor: 2.316

3.  Examination of the effects of microRNA-145-5p and phosphoserine aminotransferase 1 in colon cancer.

Authors:  Ruliang Ding; Weiwen Hong; Liang Huang; Jinfan Shao; Wenfeng Yu; Xijuan Xu
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

Review 4.  Spectrum of microRNAs and their target genes in cancer: intervention in diagnosis and therapy.

Authors:  Alti Dayakar; Kumar D Shanmukha; Suresh K Kalangi
Journal:  Mol Biol Rep       Date:  2022-01-15       Impact factor: 2.742

5.  Clinical value of peripheral blood microRNA detection in evaluation of SOX regimen as neoadjuvant chemotherapy for gastric cancer.

Authors:  Bibo Tan; Yong Li; Yan Di; Liqiao Fan; Qun Zhao; Qingwei Liu; Dong Wang; Nan Jia
Journal:  J Clin Lab Anal       Date:  2017-11-23       Impact factor: 2.352

6.  Identification of gene signatures and potential therapeutic targets for acquired chemotherapy resistance in gastric cancer patients.

Authors:  Jie Sun; Jingjing Zhao; Zhenkun Yang; Zhiyi Zhou; Peihua Lu
Journal:  J Gastrointest Oncol       Date:  2021-04

Review 7.  Getting miRNA Therapeutics into the Target Cells for Neurodegenerative Diseases: A Mini-Review.

Authors:  Ming Ming Wen
Journal:  Front Mol Neurosci       Date:  2016-11-22       Impact factor: 5.639

8.  Trehalose significantly enhances the recovery of serum and serum exosomal miRNA from a paper-based matrix.

Authors:  Shu Hui Neo; Ka Yan Chung; Jia Min Quek; Heng-Phon Too
Journal:  Sci Rep       Date:  2017-11-30       Impact factor: 4.379

9.  Prognostic value of microRNAs in gastric cancer: a meta-analysis.

Authors:  Yue Zhang; Dong-Hui Guan; Rong-Xiu Bi; Jin Xie; Chuan-Hua Yang; Yue-Hua Jiang
Journal:  Oncotarget       Date:  2017-06-21

10.  Long non-coding RNA KCNQ1OT1 promotes the progression of gastric cancer via the miR-145-5p/ARF6 axis.

Authors:  Xiongdong Zhong; Xiaoyan Wen; Lei Chen; Ni Gu; Xianchang Yu; Kang Sui
Journal:  J Gene Med       Date:  2021-04-06       Impact factor: 4.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.